Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v Irrigation Solution
- Name:
Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v Irrigation Solution
- Company:
Baxter Holding B.V.
- Active Ingredients:
- Legal Category:
Supply through pharmacy only
Click on this link to Download PDF directly
Baxter Holding B.V.
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 14 January 2020 SPC
Reasons for updating
- Correction of spelling/typing errors
Legal category: Supply through pharmacy only
Updated on 24 December 2018 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Updated on 28 December 2016 PIL
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Section 4.4 - items in red added
Anaphylactic/anaphylactoid reactions to chlorhexidine have been reported. Manifestations of such reactions have included hypotension, bronchospasm, rash, erythema, tachycardia, and shock. Fatal anaphylactic reaction has been reported.
Hypersensitivity reactions have been reported on contact with Chlorhexidine acetate or Cetrimide
If any signs or symptoms of a suspected hypersensitivity reaction develop, immediately stop use. Appropriate therapeutic countermeasures must be instituted as clinically indicated.
The use of chlorhexidine solutions, both alcohol based and aqueous, for skin antisepsis prior to invasive procedures has been associated with chemical burns in neonates. Based on available case reports and the published literature, this risk appears to be higher in preterm infants, especially those born before 32 weeks of gestation and within the first 2 weeks of life.
Remove any soaked materials, drapes or gowns before proceeding with the intervention. Do not use excessive quantities and do not allow the solution to pool in skin folds or under the patient or drip on sheets or other material in direct contact with the patient. Where occlusive dressings are to be applied to areas previously exposed to Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v Irrigation Solution, care must be taken to ensure no excess product is present prior to application of the dressing.
Caution should be exercised when chlorhexidine is used in preoperative skin preparations for face or head. (See section 4.3 Contraindications). This product should only be used in specialist units familiar with the appropriate selection of patients.
Section 4.8 items in red added/ changed
Immune system disorders:
Hypersensitivity reactions including anaphylactic/anaphylactoid reactions (which might be fatal) manifested by cardiac arrest, shock, circulatory collapse, hypotension, bronchospasm, tachycardia, rash, erythema and urticaria
Skin and subcutaneous tissue disorders:
Rash
Other Adverse Reactions:
The adverse events reported and/or observed with other chlorhexidine products include:
. Chemical burns in neonates (See Section 4.4 Special Warnings and Precaustions for Use)
The following reactions have been noted when Chlorhexidine containing irrigation solutions have been used intravesically, intravaginally or topically on traumatised skin: Hypotension, paraesthesia, dyspnea, tachycardia, cold sweat, generalised erythema, urticaria and loss of consciousness.
Chemical burns in neonates (frequency unknown).
Updated on 28 December 2016 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 4.4 - items in red added
Anaphylactic/anaphylactoid reactions to chlorhexidine have been reported. Manifestations of such reactions have included hypotension, bronchospasm, rash, erythema, tachycardia, and shock. Fatal anaphylactic reaction has been reported.
Hypersensitivity reactions have been reported on contact with Chlorhexidine acetate or Cetrimide
If any signs or symptoms of a suspected hypersensitivity reaction develop, immediately stop use. Appropriate therapeutic countermeasures must be instituted as clinically indicated.
The use of chlorhexidine solutions, both alcohol based and aqueous, for skin antisepsis prior to invasive procedures has been associated with chemical burns in neonates. Based on available case reports and the published literature, this risk appears to be higher in preterm infants, especially those born before 32 weeks of gestation and within the first 2 weeks of life.
Remove any soaked materials, drapes or gowns before proceeding with the intervention. Do not use excessive quantities and do not allow the solution to pool in skin folds or under the patient or drip on sheets or other material in direct contact with the patient. Where occlusive dressings are to be applied to areas previously exposed to Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v Irrigation Solution, care must be taken to ensure no excess product is present prior to application of the dressing.
Caution should be exercised when chlorhexidine is used in preoperative skin preparations for face or head. (See section 4.3 Contraindications). This product should only be used in specialist units familiar with the appropriate selection of patients.
Section 4.8 items in red added/ changed
Immune system disorders:
Hypersensitivity reactions including anaphylactic/anaphylactoid reactions (which might be fatal) manifested by cardiac arrest, shock, circulatory collapse, hypotension, bronchospasm, tachycardia, rash, erythema and urticaria
Skin and subcutaneous tissue disorders:
Rash
Other Adverse Reactions:
The adverse events reported and/or observed with other chlorhexidine products include:
. Chemical burns in neonates (See Section 4.4 Special Warnings and Precaustions for Use)
The following reactions have been noted when Chlorhexidine containing irrigation solutions have been used intravesically, intravaginally or topically on traumatised skin: Hypotension, paraesthesia, dyspnea, tachycardia, cold sweat, generalised erythema, urticaria and loss of consciousness.
Chemical burns in neonates (frequency unknown).
Updated on 28 December 2016 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through pharmacy only
Updated on 1 September 2016 PIL
Reasons for updating
- New SPC for medicines.ie
Free text change information supplied by the pharmaceutical company
Updated on 1 September 2016 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Supply through pharmacy only